Graft vs Host DiseaseGraft vs Host ReactionTransplantation, HomologousBone Marrow TransplantationGraft SurvivalHematopoietic Stem Cell TransplantationGraft vs Tumor EffectTransplantation ConditioningGraft vs Leukemia EffectChronic DiseaseHistocompatibilityAnemia, AplasticConsensus Development Conferences, NIH as TopicHematologic NeoplasmsLymphocyte TransfusionHistocompatibility TestingAcute DiseaseImmunosuppressive AgentsTissue DonorsPeripheral Blood Stem Cell TransplantationTransplantation ChimeraTreatment OutcomeLeukemiaGraft Occlusion, VascularWhole-Body IrradiationCord Blood Stem Cell TransplantationLymphocyte DepletionRecurrencePhotopheresisT-LymphocytesRetrospective StudiesTime FactorsMice, Inbred C57BLHLA AntigensOligohymenophoreaImmunosuppressionInfectionVidarabineAntilymphocyte SerumSkin DiseasesChimerismSpleenUnrelated DonorsSurvival AnalysisNuclear FamilyBusulfanLeukemia, Myelogenous, Chronic, BCR-ABL PositiveCyclosporineStem Cell TransplantationMinor Histocompatibility AntigensDisease-Free SurvivalLactuloseSiblingsTransplantation, IsogeneicBlood Vessel ProsthesisRadiation ChimeraT-Lymphocytes, RegulatoryMyeloablative AgonistsLichenoid EruptionsRisk FactorsHematologic DiseasesLeukocyte TransfusionMinor Histocompatibility LociMice, Inbred BALB CMethotrexateFollow-Up StudiesLife TablesCD4-Positive T-LymphocytesSurvival RateRhamnoseTransplantation ImmunologyFetal BloodDisease Models, AnimalPolytetrafluoroethyleneGraft RejectionSkinPostoperative ComplicationsProspective StudiesPrecursor Cell Lymphoblastic Leukemia-LymphomaLiving DonorsLymphocyte ActivationTacrolimusHost SpecificityHistocompatibility AntigensMyelodysplastic SyndromesActuarial AnalysisCyclophosphamideMice, Inbred StrainsFatal OutcomeBlood TransfusionIncidenceNational Institutes of Health (U.S.)Hematopoietic Stem Cell MobilizationVascular PatencyTransplantation, AutologousMice, Inbred DBAGranulocyte Colony-Stimulating FactorKidney TransplantationRemission InductionBone Marrow